Sold as Anectine, Quelicin Preservative Free, Quelicin, Sucostrin, Succinylcholine Chloride. Every FDA application for this active ingredient: 4 branded and 29 generic.
As of Nov 16, 2026, FDA lists 33 applications for Succinylcholine Chloride (sold as Anectine, Quelicin Preservative Free, Quelicin and others), first approved Aug 20, 1952, with 0 new uses approved and 0 published complete response letters.
| Shortage | Status | First posted | Updated |
|---|---|---|---|
| Succinylcholine Chloride Injection | To Be Discontinued | Jul 23, 2026 | Jul 23, 2026 |
| Aug 20, 1952 | AnectineNDA 8453 · New molecular entity | Sandoz | 24 | Marketed |
| Apr 24, 1953 | SucostrinNDA 8847 · New formulation or manufacturer | Apothecon | 8 | Discontinued |
| May 1, 1953 | Quelicin Preservative Free, QuelicinNDA 8845 · New formulation or manufacturer | Hospira | 48 | Marketed |
| Sep 20, 1972 | Succinylcholine ChlorideANDA 80997 | Organon USA Inc | 4 | Discontinued |
| May 4, 2018 | Succinylcholine ChlorideANDA 209467 | Zydus Pharms | 3 | Marketed |
| Jun 4, 2018 | Succinylcholine ChlorideANDA 210231 | J Molner | 3 | Marketed |
| Nov 16, 2018 | Succinylcholine ChlorideANDA 211432 | Amneal | 3 | Discontinued |
| Aug 2, 2019 | Succinylcholine ChlorideANDA 210698 | Dr Reddys | 3 | Marketed |
| Oct 9, 2019 | Succinylcholine ChlorideANDA 212638 | Breckenridge | 1 | Discontinued |
| Jan 15, 2020 | Succinylcholine ChlorideANDA 211589 | Somerset Theraps LLC | 2 | Marketed |
| May 4, 2020 | Succinylcholine ChlorideANDA 213810 | Aspiro | 3 | Marketed |
| May 19, 2020 | Succinylcholine ChlorideANDA 211625 | Nivagen | 2 | Marketed |
| May 20, 2020 | Succinylcholine ChlorideANDA 213705 | Accord Hlthcare | 1 | Discontinued |
| May 22, 2020 | Succinylcholine ChlorideANDA 214308 | Regcon Holdings | 2 | Marketed |
| Jun 8, 2020 | Succinylcholine ChlorideANDA 213432 | Amphastar Pharms Inc | 2 | Discontinued |
| Jun 12, 2020 | Succinylcholine ChlorideANDA 213229 | Hikma | 4 | Marketed |
| Jun 16, 2020 | Succinylcholine ChlorideANDA 214246 | Gland | 2 | Marketed |
| Oct 27, 2020 | Succinylcholine ChlorideANDA 213552 | Nexus | 0 | Discontinued |
| Nov 20, 2020 | Succinylcholine ChlorideANDA 211346 | Fresenius Kabi USA | 3 | Marketed |
| Nov 24, 2020 | Succinylcholine ChlorideANDA 214879 | Micro Labs | 3 | Marketed |
| Dec 21, 2020 | Succinylcholine ChlorideANDA 214491 | Deva Holding As | 0 | Marketed |
| Mar 29, 2021 | Succinylcholine ChlorideANDA 215022 | Sagent Pharms Inc | 2 | Marketed |
| Aug 20, 2021 | Succinylcholine ChlorideNDA 215143 · New formulation or manufacturer | Hikma | 2 | Discontinued |
| Oct 19, 2021 | Succinylcholine ChlorideANDA 214514 | Meitheal | 0 | Marketed |
| Feb 7, 2022 | Succinylcholine ChlorideANDA 216003 | Be Pharms | 2 | Marketed |
| Feb 2, 2023 | Succinylcholine ChlorideANDA 216127 | Mankind Pharma | 0 | Discontinued |
| Oct 16, 2023 | Succinylcholine ChlorideANDA 217808 | Eugia Pharma | 0 | Discontinued |
| Jan 17, 2024 | Succinylcholine ChlorideANDA 218467 | Dr Reddys | 0 | Marketed |
| Jul 9, 2024 | Succinylcholine ChlorideANDA 217873 | Steriscience | 1 | Marketed |
| Sep 24, 2024 | Succinylcholine ChlorideANDA 218878 | Baxter Hlthcare Corp | 0 | Marketed |
| Feb 11, 2025 | Succinylcholine ChlorideANDA 217884 | Fresenius Kabi USA | 0 | Marketed |
| Feb 21, 2025 | Succinylcholine ChlorideANDA 217885 | Fresenius Kabi USA | 0 | Marketed |
| — | Succinylcholine ChlorideANDA 85400 | Intl Medication | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA